# Safety and Efficacy of Ticagrelor Versus Clopidogrel in Asian/KOREAn Patients With Acute Coronary Syndromes Intended for Invasive Management

> **NCT02094963** · PHASE4 · COMPLETED · sponsor: **Seung-Jung Park** · enrollment: 800 (actual)

## Conditions studied

- Acute Coronary Syndrome
- Myocardial Ischemia
- Heart Diseases
- Cardiovascular Diseases
- Angina Pectoris

## Interventions

- **DRUG:** Ticagrelor
- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT02094963
- **Lead sponsor:** Seung-Jung Park
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07-05
- **Primary completion:** 2018-11-01
- **Final completion:** 2018-11-01
- **Target enrollment:** 800 (ACTUAL)
- **Last updated:** 2018-11-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02094963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02094963, "Safety and Efficacy of Ticagrelor Versus Clopidogrel in Asian/KOREAn Patients With Acute Coronary Syndromes Intended for Invasive Management". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT02094963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*